MAP2K6
MAP2K6 (mitogen-activated protein kinase kinase 6, also known as MEK6, MKK6, SAPKK3 and MAPKK6) is a dual specificity protein kinase in the MAP kinase signalling cascade. It activates p38 MAP kinases in response to cytokines and cellular stress. Browse Assay Genie's current range of MAP2K6 research reagents below, or read on for the biology behind the target.
MAP2K6 is a dual specificity protein kinase and an essential component of the MAP kinase signal transduction pathway. Together with MAP3K3/MKK3, it catalyses the concomitant phosphorylation of a threonine and a tyrosine residue in the p38 MAP kinases MAPK11, MAPK12, MAPK13 and MAPK14, and so helps regulate cellular responses to cytokines and many kinds of stress. MAP2K3 and MAP2K6 are both essential for activation of MAPK11 and MAPK13 induced by environmental stress, while MAP2K6 is the major MAPK11 activator in response to TNF. It also phosphorylates and activates PAK6.
The p38 MAP kinase pathway leads to direct activation of transcription factors, with nuclear targets that include ATF2 and ELK1. Through MAPK14 activation, MAP2K6 mediates phosphorylation of STAT4, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression, for down-regulation of IL-6-mediated gene induction, and for IFNG-dependent gene transcription. Further roles include osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, endochondral ossification (SOX9 is a likely downstream target of p38 signalling), apoptotic cell death in thymocytes, and regulation of melanocyte dendricity through modulation of Rho family GTPases.
The MAP2K6 protein belongs to the STE Ser/Thr protein kinase family, MAP kinase kinase subfamily, within the protein kinase superfamily, and sits in the HGNC gene group of mitogen-activated protein kinase kinases. The MAP2K6 gene is also listed under the symbols CRCMSL and PRKMK6. According to the NCBI Gene summary, it contributes to stress-induced cell cycle arrest, transcription activation and apoptosis. The mouse ortholog is Map2k6.
MAP2K6 phosphorylates MAPK11, MAPK12, MAPK13 and MAPK14, making it a key node for studying activation of the p38 stress-response pathway.
MAP2K6 links TNF, IL-12, IL-6 and IFNG signals to gene expression, including STAT4 activation and SOCS3 induction.
The kinase is involved in stress-induced cell cycle arrest and apoptosis, including apoptotic cell death in thymocytes.
MAP2K6 has a role in osteoclast differentiation and in endochondral ossification, with SOX9 a likely downstream target of p38 signalling.
MAP2K6 is a dual specificity kinase that phosphorylates a threonine and a tyrosine residue in p38 MAP kinases (MAPK11, MAPK12, MAPK13 and MAPK14). This drives cellular responses to cytokines and stress, activating transcription factors such as ATF2 and ELK1.
MAP2K6 is also called MEK6, MKK6, SAPKK3 and MAPKK6, and the gene has also appeared as PRKMK6 and CRCMSL. The UniProt entry names it dual specificity mitogen-activated protein kinase kinase 6, and its enzyme classification is EC 2.7.12.2.
Both are essential for activating MAPK11 and MAPK13 under environmental stress. MAP2K6 is the major MAPK11 activator in response to TNF. It also phosphorylates PAK6. A mouse ortholog, Map2k6, exists; check the datasheet of any product for its validated reactivity.
Other MAP kinase kinases, upstream MAP3K kinases and related signalling kinases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P52564; product specifications from Assay Genie datasheets.